Literature DB >> 23140984

Acoustic impairment is a distinguishable clinical feature of Asidan/SCA36.

Yoshio Ikeda1, Yasuyuki Ohta, Tomoko Kurata, Yoshihiko Shiro, Yoshiki Takao, Koji Abe.   

Abstract

OBJECTIVE: To investigate acoustic function of Asidan/spinocerebellar ataxia type 36 (SCA36) in which sensorineural hearing loss may be found as one of extracerebellar symptom that can be a distinguishable feature from other degenerative ataxias.
METHODS: Acoustic function in the groups of normal control (n=31), Asidan/SCA36 (n=13), cortical cerebellar atrophy (CCA, n=28), multiple system atrophy of cerebellar predominance (MSA-C, n=48), SCA31 (n=4), and other forms of SCAs (n=14) was evaluated by pure tone average (PTA) calculated by the results of audiogram and brainstem auditory evoked potentials (BAEPs).
RESULTS: PTA was significantly decreased in Asidan/SCA36 in comparison to normal control and other ataxic groups, but not significant within other ataxic groups and normal control. In comparison to other groups, Asidan/SCA36 showed a constant depression at 7 different frequencies in audiogram, especially at 4000 and 8000 Hz. BAEPs in 2 Asidan/SCA36 cases suggested possible involvement in the inner ear or the peripheral part of the auditory system. PTA in Asidan/SCA36 cases significantly correlated with their severity of ataxia.
CONCLUSIONS: In addition to signs for motor neuron involvement, acoustic impairment in Asidan/SCA36 is another characteristic clinical feature that is distinguishable from other forms of SCAs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23140984     DOI: 10.1016/j.jns.2012.10.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.

Authors:  Zachary T McEachin; Tania F Gendron; Nisha Raj; María García-Murias; Anwesha Banerjee; Ryan H Purcell; Patricia J Ward; Tiffany W Todd; Megan E Merritt-Garza; Karen Jansen-West; Chadwick M Hales; Tania García-Sobrino; Beatriz Quintáns; Christopher J Holler; Georgia Taylor; Beatriz San Millán; Susana Teijeira; Toru Yamashita; Ryuichi Ohkubo; Nicholas M Boulis; Chongchong Xu; Zhexing Wen; Nathalie Streichenberger; Brent L Fogel; Thomas Kukar; Koji Abe; Dennis W Dickson; Manuel Arias; Jonathan D Glass; Jie Jiang; Malú G Tansey; María-Jesús Sobrido; Leonard Petrucelli; Wilfried Rossoll; Gary J Bassell
Journal:  Neuron       Date:  2020-05-05       Impact factor: 17.173

2.  Altered Brain Volume, Microstructure Metrics and Functional Connectivity Features in Multiple System Atrophy.

Authors:  Yunxiang Ge; Weimin Zheng; Yujia Li; Weibei Dou; Shan Ren; Zhigang Chen; Zhiqun Wang
Journal:  Front Aging Neurosci       Date:  2022-05-19       Impact factor: 5.702

3.  Sensorineural Hearing Loss in Non-depressed Essential Tremor Cases and Controls: A Clinical and Audiometric Study.

Authors:  Nesrin Helvaci Yilmaz; Muhittin Cenk Akbostanci; Nurhan Yılmaz
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-01-29

Review 4.  Spinocerebellar Ataxia 36: From Mutations Toward Therapies.

Authors:  Samuel Lopez; Fang He
Journal:  Front Genet       Date:  2022-03-04       Impact factor: 4.599

5.  Spinocerebellar ataxia type 36 in the Han Chinese.

Authors:  Yi-Chung Lee; Pei-Chien Tsai; Yuh-Cherng Guo; Cheng-Tsung Hsiao; Guan-Ting Liu; Yi-Chu Liao; Bing-Wen Soong
Journal:  Neurol Genet       Date:  2016-04-12

6.  Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38).

Authors:  Barbara Borroni; Eleonora Di Gregorio; Laura Orsi; Giovanna Vaula; Chiara Costanzi; Filippo Tempia; Nico Mitro; Donatella Caruso; Marta Manes; Lorenzo Pinessi; Alessandro Padovani; Alfredo Brusco; Loredana Boccone
Journal:  Parkinsonism Relat Disord       Date:  2016-04-27       Impact factor: 4.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.